Femto Technologies バランスシートの健全性
財務の健全性 基準チェック /66
Femto Technologiesの総株主資本はCA$35.0M 、総負債はCA$0.0で、負債比率は0%となります。総資産と総負債はそれぞれCA$35.9MとCA$872.7Kです。
主要情報
0%
負債資本比率
CA$0
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | CA$15.23m |
| エクイティ | CA$35.00m |
| 負債合計 | CA$872.71k |
| 総資産 | CA$35.87m |
財務の健全性に関する最新情報
Recent updates
Seeking Alpha • Sep 30
BYND Cannasoft Enterprises announces $649,500 private placement
BYND Cannasoft Enterprises (NASDAQ:BCAN) to raise up to C$649,500 from certain investors by way of a non-brokered private placement. Specifically, the company has agreed to issue up to 150,000 shares at an issue price of $4.33 per share. Private placement is scheduled to close prior to the end of October.Seeking Alpha • Sep 13
BYND Cannasoft: New CRM Platform Disrupts The Medical Cannabis Industry
Summary BYND Cannasoft Enterprises Inc. has been marketing its proprietary CRM software known as Benefit CRM to approximately 400 clients with a monthly recurring revenue model for close to 20 years. BYND Cannasoft Enterprises could be entering a phase of unprecedented growth as it introduces its new CRM platform to meet the needs of the medical cannabis industry. According to the Israeli Medical Cannabis Agency, as of November 2021, Israel had 110,000 medical cannabis license holders. In addition to helping cannabis growers manage their day-to-day business activities, BYND Cannasoft's New Cannabis CRM Platform could ultimately become the "virtual marketplace" for all stakeholders in medical cannabis. BYND Cannasoft Enterprises Inc. (BCAN, BYND.CA) has been marketing its proprietary customer relationship management (CRM) software product known as Benefit CRM to approximately 400 clients with a monthly recurring revenue model for close to 20 years. BYND Cannasoft Enterprises' Benefit CRM software enables small and medium-sized businesses to optimize their day-to-day business activities, such as sales management, personnel management, marketing, call center activities, and asset management. Benefit 2.0 software is an advanced generation of cloud database management software currently used by dozens of the company's clients in Israel. According to BYND Cannasoft Enterprises' Storydoc website, current customers include Soreq Nuclear Research Center and Harel Insurance Investments and Financial Services Ltd. Soreq Nuclear Research Center is Israel's nuclear reactor. Harel Insurance Investments is one of the most comprehensive insurance and financial services companies in Israel, with more than 80 years of insurance experience. Others include the Ness Group, One for Israel, and Perrigo Israel Pharmaceuticals Ltd. Ness is a private company that provides comprehensive computing services in the business and educational sectors. One for Israel is an Israeli-based IT company employing nearly 4,000 experts in Israel and globally to provide computer-based solutions to more than 2,000 clients and tens of thousands of users. Perrigo Israel develops, manufactures, and markets Generic Pharmaceuticals and Active Pharmaceutical ingredients. It has three manufacturing sites worldwide. BYND Cannasoft Enterprises Current Customers Incude Some of Israel's Largest Companies (Company website) Medical Cannabis CRM Software Building on its 20 years of experience in CRM software, BYND Cannasoft Enterprises recently began the development of a new CRM platform designed to serve the needs of the medical cannabis industry. BYND Cannasoft Enterprises is looking to transform the sector into a more organized, accessible, and price transparent market. BYND Cannasoft's goal is that its New Cannabis CRM Platform will ultimately become the "virtual marketplace" for all stakeholders in medical cannabis, which is similar to what Jack Ma did with Alibaba (BABA). In addition to the virtual marketplace, the CRM and ERP system will allow growers a deep insight into all aspects of managing a cannabis farm and cannabis distribution, from the amounts of fertilizer to tracking delivery revenue. The ERP system will help cannabis growers manage their day-to-day business activities like supply chain operations, accounting, procurement, project management, risk management, and compliance. BYND Cannasoft's medical cannabis software has completed its first development phase and is currently installed in one entity in this field in Israel. Cannabis stocks have had a mixed year, led by companies like Aurora Cannabis (ACB), Canopy Growth Corp (CGC), and Cronos Group (CRON). However, BYND Cannasoft could provide a boost to the industry as its CRM platform catches on. This new platform could be a first for the medical cannabis field. Cannabis growers have been affected by the covid-19 pandemic and the war in Ukraine. Since Ukraine and Russia export 28% of the world's fertilizers, supply chains have been upset by war and economic sanctions. During the pandemic, consumers spent more money on cannabis than ever before, which meant growers had to produce a lot more cannabis to meet demand. Cannabis sales increased during the covid-19 pandemic, as many people were homebound. Now that the pandemic is winding down and people are returning to work, supply outweighs the current demand for cannabis. If you remember back to introductory economics, we generally see a price decline if supply is more significant than demand. Lower prices do not necessarily mean growers need to throw in the towel on their cannabis crops, but they need to be more aware of their costs and inventory, which is where BYND Cannasoft Enterprises comes in. BCAN data by YCharts Cannabis Farm BYND Cannasoft Enterprises has a growing license in Israel, and it has been working with the Bezinzsky family (a medical cannabis license holder) to establish a medical cannabis farm. The company has made the following progress: It is currently working on transferring the initial permit for the cultivation and multiplication of medical cannabis according to the partnership agreement with the Bezinsky family. After its transfer, the company will operate for the planning and construction of a growing facility in Moshav Kochav Michael. The company has completed the planning and placement of an internal breeding facility and has applied for a breeding license. BYND Cannasoft Enterprises has applied for a license to trade in medical cannabis "without contact with the substance," also known as a constructive license. After receiving the permit, the company can implement agreements it has signed with various growers for marketing and selling the company's private label. BYND Cannasoft Enterprises plans to develop its cannabis farm near Ashkelon, Israel, on 3.5 acres (15 dunams) of land with an option to expand the farm to twice that size. The IMC-GDP license is an exclusive license issued by the Ministry of Health - The Israeli Medical Cannabis Unit for importing, distributing, and storing cannabis for medical use in a designated facility. BYND Cannasoft Enterprises aims to receive the IMC-GMP licenses within the year and will mainly export to Germany once regulation permits. BYND Cannasoft Enterprises is in the final stages of obtaining its license. Immediately after receiving its license, the company management said it would have products on the shelves. During this time, BYND Cannasoft Enterprises has obtained a separate license that allows the company to enter into a contract with one of the existing growers in Israel to build a private label of products for the company. BYND Cannasoft Enterprises intends to market these products to pharmacies to generate revenues without the required investment in establishing and operating a growing facility. The agreement with the grower includes marketing in Israel and the marketing of BYND Cannasoft Enterprises' brand to Germany through the grower's growing farm in Uganda. BYND Cannasoft Enterprises’ plans include the construction of 4 state-of-the-art greenhouses, housing approximately 2.5 acres of total growing area. The company estimates that, once fully operational, its Cannabis farm facility will be able to produce 7,500 kg, or 16,534 pounds, of raw cannabis each year. BYND Cannasoft Enterprises also intends to work with strategic partners to develop and market proprietary cannabis-infused products for the Israeli and global markets. The data and information collected through the operation of the cannabis farm and the products it produces will also allow BYND Cannasoft Enterprises to test its new Cannabis CRM platform and adjust the platform as necessary. BYND Cannasoft Enterprises' long-term goal is to leverage its cannabis farm business to assist in developing its New Cannabis CRM Platform. Utilizing data from growing, harvesting, and selling medical cannabis at its cannabis farm, BYND Israel can optimize its New Cannabis CRM Platform to offer stakeholders in the Cannabis industry a state-of-the-art resource that will enhance their businesses. Q2 2022 Financial Highlights According to an August 12, 2022 press release, BYND Cannasoft Enterprises reported financial results for the six months ending June 30, 2022. Complete versions of BYND Cannasoft Enterprises' financial statements can be found on www.sedar.com. As a result of the move toward its cannabis CRM platform, BYND Cannasoft Enterprises posted revenue of $662,932 for the first half of 2022, compared with $662,728 for the same period in 2021. Gross Profit increased to 59% for the first half of 2022 from 48% for the same period in 2021. Net loss decreased 86% to $638,669 for the first half of 2022 from $4,543,591 for the same period in 2021. Working capital decreased to 3,988,467 for June 30, 2022 from $5,487,201 for December 31,2021. The total number of shares outstanding as of June 30, 2022, was 29,670,083. Below is a Table Listing a Summary of the Quarterly Comparison of Revenue, Gross Profit, and Net Income (Loss) taken from the August 12, 2022 press release Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Revenue $207,653 $455,279 $258,303 $296,428 $418,635 $244,093 Gross Profit $37,657 $355,111 $126,591 $157,439 $260,167 $78,941 Net Income (Loss) $(473,386) $(165,283) $(271,932) $(59,279) $(103,753) $(4,443,774)* *Includes a one-time non-recurring non-cash $4,394,390 listing expense incurred due to the Business Combination Transactions and the company’s listing of its shares on the CSE. Management The following management bios have been consolidated from BYND Cannasoft Enterprises’ Storydoc website. Moti Maram President and Director In 1986, Mr. Maram partnered to found a computer company that mainly provided services to EXATEC-compliant IBM AS 400 computers and sales and service to the first PCs in the world. After identifying a need for CRM and ERP software, Maram and his partner, Avner Tal, established a software company that manufactures CRM and ERP management software called BENEFIT in 2000. Yftah Ben Yaackov CEO and Director Mr. Yaackov has been a professional lawyer since 2004. He specialized in real estate-related issues, including real estate corporations, complex sales transactions, real estate unions, and real estate taxation. His recent experience includes managing large projects exceeding tens of thousands of square meters with budgets exceeding 400 million NIS ($115 million). Over the last five years, Mr. Yaackov has assembled the business activity of two of the largest medical cannabis companies in Israel, providing him with tremendous experience and knowledge in this field. Avner Tal VP Sales & Marketing, CTO, and Director Mr. Tal currently serves as the Technology Director of Beyond Solution Company. After studying electronics and control, he served in the Navy on the team that implemented and developed the technology that included "smart" missiles. He came to BYND Cannasoft Enterprises after working with Moti Maram to establish the computer company that supported Exatech computers and its innovative network. Gabi Kabazo CFO and Director Gabi is a seasoned finance and operations professional with over 20 years of experience supporting accounting, finance, and IT operations in complex corporate settings. Since 2009, Mr. Kabazo has been with TELUS Telecommunications Company. From 2002-2011 he served as CFO for m-Wise Inc. He received B.A from TAU and M.B.A from UBC in Accounting & Economics. Dr. Stefánia Szabó Director財務状況分析
短期負債: FMTO.Fの 短期資産 ( CA$16.1M ) が 短期負債 ( CA$804.7K ) を超えています。
長期負債: FMTO.Fの短期資産 ( CA$16.1M ) が 長期負債 ( CA$68.0K ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: FMTO.Fは負債がありません。
負債の削減: FMTO.Fは現在負債はありませんが、その期間のデータがないため、5 年前と比較することはできません。
債務返済能力: FMTO.Fには負債がないため、営業キャッシュフロー でカバーする必要はありません。
インタレストカバレッジ: FMTO.Fには負債がないため、利息支払い の負担は問題になりません。
貸借対照表
健全な企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/26 21:31 |
| 終値 | 2026/05/19 00:00 |
| 収益 | 2025/12/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Femto Technologies Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0